(Re)framing menopause: a comprehensive public health approach

Authors:

Abstract
Over half of the world’s population will experience menopause, the point in time 12 months after a woman’s final menstrual period ( World Health Organization, 2022). Most women experience menopause between 45 and 54 years of age ( Namazi et al., 2019). Perimenopause, the period leading up to and one year after menopause, is characterized by the fluctuation and decline of key hormones, which cause menopausal symptoms in most—but not all—women ( World Health Organization, 2022). The most common symptoms include irregular periods, vasomotor symptoms (commonly known as ‘hot flushes’ and ‘night sweats’), and genito-urinary symptoms, as well as mental fatigue, ‘brain fog’, joint pain and insomnia which can negatively impact women’s wellbeing and quality of life ( Panay et al., 2021). Most menopause research to date has focused on the medicalized symptoms and management of menopause ( Nappi et al., 2021; Crandall et al., 2023). While these studies are important, describing menopause purely in terms of physiology and symptomology misses a broader range of socio-cultural, environmental, commercial and political determinants that are instrumental in developing comprehensive responses which promote the health and wellbeing of populations.

This publication has 28 references indexed in Scilit: